Oxford VR

Oxford VR is a pioneering startup focused on empowering mental health through faster, more effective, and cost-efficient VR treatments. Spun out from Oxford University and led by Professor Daniel Freeman, the company leverages 15 years of innovative research to develop clinically validated, user-centered solutions. Their VR-based treatments offer greater efficacy compared to traditional methods, while also significantly reducing costs for healthcare providers. Dedicated to addressing conditions with a substantial impact on patients, the healthcare system, and the economy, Oxford VR operates within the Health Care industry. In 2016, the startup attracted a noteworthy $500.00K grant investment from Mission Daybreak, signaling confidence in its innovative approach. This investment supports the company's mission to provide millions of efficient and effective treatments using highly immersive consumer VR technology. Oxford VR's commitment to pioneering mental health interventions raises the bar for industry standards. With their focus on user satisfaction and cost-efficiency, they stand out as a compelling opportunity for investors seeking both social impact and financial returns.